Publikationen

Publikationen

JahrPublikation
2024 Bouvier AM, Jooste V, Lillini R, Marcos-Gragera R, Katalinic A, Giorgi Rossi P, Launoy G, Bouvier V, Guevara M, Ardanaz E, Rapiti Aylward E, Innos K, Barranco MR, Sant M. Differences in survival and recurrence of colorectal cancer by stage across population-based European registries. Int J Cancer. 2024;155(5):807-15;doi: 10.1002/ijc.34944.
2024 De Angelis R, Demuru E, Baili P, Troussard X, Katalinic A, Chirlaque Lopez MD, Innos K, Santaquilani M, Blum M, Ventura L, Paapsi K, Galasso R, Guevara M, Randi G, Bettio M, Botta L, Guzzinati S, Dal Maso L, Rossi S. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study. Lancet Oncol. 2024;25(3):293-307;doi: 10.1016/s1470-2045(23)00646-0.
2024 Eisemann N, Schumann L, Baltus H, Labohm L, Kraywinkel K, Katalinic A. Longer Survival From Melanoma in Germany: A Registry-Based Time Series Study. Dtsch ?rztebl Int. 2024;121(2):45-51;doi: 10.3238/arztebl.m2023.0242.
2024 Germer S, Rudolph C, Labohm L, Katalinic A, Rath N, Rausch K, Holleczek B, Handels H. Survival analysis for lung cancer patients: A comparison of Cox regression and machine learning models. International journal of medical informatics. 2024;191:105607;doi: 10.1016/j.ijmedinf.2024.105607.
2024 Grieger P, Eisemann N, Hammersen F, Rudolph C, Katalinic A, Waldmann A. Initial Evidence of a Possible Effect of HPV Vaccination on Cancer Incidence in Germany?Focus on Cervical Cancer. Dtsch ?rztebl Int. 2024;121(13):415-21;doi: 10.3238/arztebl.m2024.0062.
2024 Katalinic A. Reply: Absence of evidence is not evidence of absence for first trimester dydrogesterone-induced birth defects. Human reproduction open. 2024;2024(2):hoae031;doi: 10.1093/hropen/hoae031.
2024 Katalinic M, Schenk M, Franke S, Katalinic A, Neumuth T, Dietz A, Stoehr M, Gaebel J. Generation of a Realistic Synthetic Laryngeal Cancer Cohort for AI Applications. Cancers (Basel). 2024;16(3);doi: 10.3390/cancers16030639.
2024 Nanz L, Keim U, Katalinic A, Meyer T, Garbe C, Leiter U. Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma. Cancers (Basel). 2024;16(3);doi: 10.3390/cancers16030606.
2024 Schulz NA, Carus J, Wiederhold AJ, Johanns O, Peters F, Rath N, Rausch K, Holleczek B, Katalinic A, Gundler C. Learning debiased graph representations from the OMOP common data model for synthetic data generation. BMC Med Res Methodol. 2024;24(1):136;doi: 10.1186/s12874-024-02257-8.
2024 Schumann L, Hadwiger M, Eisemann N, Katalinic A. Lead-Time Corrected Effect on Breast Cancer Survival in Germany by Mode of Detection. Cancers (Basel). 2024;16(7);doi: 10.3390/cancers16071326.
2024 Trama A, Botta L, Stiller C, Visser O, Ca?ete-Nieto A, Spycher B, Bielska-Lasota M, Katalinic A, Vener C, Innos K, Marcos-Gragera R, Paapsi K, Guevara M, Demuru E, Mousavi SM, Blum M, Eberle A, Ferrari A, Bernasconi A, Lasalvia P. Survival of European adolescents and young adults diagnosed with cancer in 2010-2014. Eur J Cancer. 2024;202:113558;doi: 10.1016/j.ejca.2024.113558.
2023 Demuru E, Rossi S, Ventura L, Dal Maso L, Guzzinati S, Katalinic A, Lamy S, Jooste V, Di Benedetto C, De Angelis R, tE-WG. Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes. Frontiers in Oncology. 2023;13;doi: 10.3389/fonc.2023.1114701.
2023 Garbe C, Augustin M, Augustin J, Baltus H, Eisemann N, H?bner J, Katalinic A, Wolf S, Hagenstr?m K. Evaluation of skin cancer screening in Germany - participation, tumor detection and interval tumors based on SHI data. J Dtsch Dermatol Ges. 2023;21(S5):3-11;doi: 10.1111/ddg.15170.
2023 H?bner J, Baltus H, Eisemann N, Rohr M, Schumann L, Augustin J, Hagenstr?m K, Wolf S, Garbe C, Augustin M, Katalinic A. Evaluation of early skin cancer detection in Germany with cancer registry data - challenges, solutions and current trends. J Dtsch Dermatol Ges. 2023;21(S5):13-20;doi: 10.1111/ddg.15171.
2023 Heywang-K?brunner SH, Hacker A, J?nsch A, Hertlein M, Mieskes C, Elsner S, Sinnatamby R, Katalinic A. Use of novel artificial intelligence computer-assisted detection (AI-CAD) for screening mammography: an analysis of 17,884 consecutive two-view full-field digital mammography screening exams. Acta Radiol. 2023;64(10):2697-703;doi: 10.1177/02841851231187382.
2023 Katalinic A, Halber M, Meyer M, Pfl?ger M, Eberle A, Nennecke A, Kim-Wanner SZ, Hartz T, Weitmann K, Stang A, Justenhoven C, Holleczek B, Piontek D, Wittenberg I, He?mer A, Kraywinkel K, Spix C, Pritzkuleit R. Population-Based Clinical Cancer Registration in Germany. Cancers (Basel). 2023;15(15);doi: 10.3390/cancers15153934.
2023 Katalinic A, Pritzkuleit R, Kraywinkel K. Forschung mit Krebsregistern ? was geht, was (noch) nicht? Die Onkologie. 2023;doi: 10.1007/s00761-023-01426-6.
2023 Keim U, Katalinic A, Holleczek B, Wakkee M, Garbe C, Leiter U. Incidence, mortality and trends of cutaneous squamous cell carcinoma in Germany, the Netherlands, and Scotland. Eur J Cancer. 2023;183:60-8;doi: https://doi.org/10.1016/j.ejca.2023.01.017.
2023 Pritzkuleit R, Eisemann N, Schumann L, Katalinic A. Faktenblatt: Epidemiologie des malignen Melanoms der Haut in Deutschland. Die Onkologie. 2023;29(8):660-4;doi: https://doi.org/10.1007/s00761-023-01367-0.
2023 Schliemann A, Teroerde A, Beurer B, Hammersen F, Fischer D, Katalinic A, Labohm L, Strobel AM, Waldmann A. Reduced Psychosocial Well-Being among the Children of Women with Early-Onset Breast Cancer. Current Oncology. 2023;30(12):10057-74;doi: 10.3390/curroncol30120731.
2023 Schumann L, Eisemann N, Augustin J, Kieschke J, Meyer M, Kaj?ter H, Katalinic A. Association of early-stage incidence and mortality in malignant melanoma - a population-based ecological study. J Dtsch Dermatol Ges. 2023;21(S5):33-40;doi: 10.1111/ddg.15218.
2023 Struck JP, Ozimek T, Schnoor M, Offermann A, Guenther M, Roesch MC, Wie?meye JR, Katalinic A, Perner S, Borgmann H, Merseburger AS, Kramer MW. The Role of Urine and Washing Cytology in Primary Transurethral Resection of Bladder Tumours. Urol Int. 2023;107(8):792-800;doi: 10.1159/000531443.
2023 Waldmann A, Borchers P, Katalinic A. Temporal trends in age- and stage-specific incidence of colorectal adenocarcinomas in Germany. BMC Cancer. 2023;23(1):1180;doi: 10.1186/s12885-023-11660-1.
2023 Wolf S, Augustin M, Hagenstr?m K, Garbe C, Baltus H, Eisemann N, H?bner J, Katalinic A, Augustin J. Evaluation of skin cancer screening in Germany - Spatiotemporal associations between skin cancer screening and skin cancer mortality based on ambulatory claims data. J Dtsch Dermatol Ges. 2023;21(S5):22-31;doi: 10.1111/ddg.15172.
2022 Pigeot I, Bongaerts B, Eberle A, Katalinic A, Kieschke J, Luttmann S, Meyer M, Nennecke A, Rathmann W, Stabenow R, Wilsdorf-K?hler H, Kollhorst B, Reinders T. [Linkage of claims data with data from epidemiological cancer registries: possibilities and limitations in the German federal states]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022;65(2):615-23;doi: 10.1007/s00103-021-03475-x.
2022 Schmutzler RK, Schmitz-Luhn B, Borisch B, Devilee P, Eccles D, Hall P, Balma?a J, Boccia S, Dabrock P, Emons G, Gaissmaier W, Gronwald J, Houwaart S, Huster S, Kast K, Katalinic A, Linn SC, Moorthie S, Pharoah P, Rhiem K, Spranger T, Stoppa-Lyonnet D, van Delden JJM, van den Bulcke M, Woopen C. Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors. Breast care (Basel, Switzerland). 2022;17(2):208-23;doi: 10.1159/000517182.
2022 Shan L, Zhang L, Zhu X, Wang Z, Fang S, Lin J, Wang J, Li N, Liu H, Zhang X, Feng Y, Liu J, Pan J, Ye G, Yu X, Tufman A, Katalinic A, Goldmann T, Petersen F, Jiang J, Geng G, Yu X. Chinese never smokers with adenocarcinoma of the lung are younger and have fewer lymph node metastases than smokers. Respiratory research. 2022;23(1):293;doi: 10.1186/s12931-022-02199-z.
2022 Thiessen H, K?ding N, Gebel B, Borsche M, Graspeuntner S, Kirchhoff L, Ehlers M, Rahm?ller J, Taube S, Kramer J, Klein C, Katalinic A, Rupp J. Risk assessment of SARS-CoV-2 transmission in hospitality employees in a highly frequented tourist area. Heliyon. 2022;8(12):e12177;doi: 10.1016/j.heliyon.2022.e12177.
2021 Bouvier AM, Jooste V, Sanchez-Perez MJ, Bento MJ, Rocha Rodrigues J, Marcos-Gragera R, Carmona-Garcia MC, Luque-Fernandez MA, Minicozzi P, Bouvier V, Innos K, Sant M. Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study. Dig Liver Dis. 2021;53(5):639-45;doi: 10.1016/j.dld.2021.01.021.
2021 Cardoso R, Guo F, Heisser T, Hackl M, Ihle P, De Schutter H, Van Damme N, Valerianova Z, Atanasov T, M?jek O, Mu??k J, Nilbert MC, Tybjerg AJ, Innos K, M?gi M, Malila N, Bouvier AM, Bouvier V, Launoy G, Woronoff AS, Cariou M, Robaszkiewicz M, Delafosse P, Poncet F, Katalinic A, Walsh PM, Senore C, Rosso S, Vincer?evskien? I, Lemmens V, Elferink MAG, Johannesen TB, K?rner H, Pfeffer F, Bento MJ, Rodrigues J, Alves da Costa F, Miranda A, Zadnik V, ?agar T, Lopez de Munain Marques A, Marcos-Gragera R, Puigdemont M, Galceran J, Carulla M, Chirlaque MD, Ballesta M, Sundquist K, Sundquist J, Weber M, Jordan A, Herrmann C, Mousavi M, Ryzhov A, Hoffmeister M, Brenner H. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol. 2021;22(7):1002-13;doi: 10.1016/s1470-2045(21)00199-6.
2021 Garbe C, Keim U, Gandini S, Amaral T, Katalinic A, Holleczek B, Martus P, Flatz L, Leiter U, Whiteman D. Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943-2036. Eur J Cancer. 2021;152:18-25;doi: https://doi.org/10.1016/j.ejca.2021.04.029.
2021 Hammersen F, Pursche T, Fischer D, Katalinic A, Waldmann A. Psychosocial and family-centered support among breast cancer patients with dependent children. Psychooncology. 2021;30(3):361-8;doi: 10.1002/pon.5585.
2021 Keim U, Gandini S, Amaral T, Katalinic A, Holleczek B, Flatz L, Leiter U, Whiteman D, Garbe C. Cutaneous melanoma attributable to UVR exposure in Denmark and Germany. Eur J Cancer. 2021;159:98-104;doi: https://doi.org/10.1016/j.ejca.2021.09.044.
2021 Krensel M, Petersen J, Stephan B, Katalinic A, Augustin J. Comparison of patient pathways in the early detection of skin cancer - a claims data analysis. J Dtsch Dermatol Ges. 2021;19(3):389-98;doi: 10.1111/ddg.14318.
2021 Lillini R, Tittarelli A, Bertoldi M, Ritchie D, Katalinic A, Pritzkuleit R, Launoy G, Launay L, Guillaume E, ?agar T, Modonesi C, Meneghini E, Amati C, Di Salvo F, Contiero P, Borgini A, Baili P. Water and Soil Pollution: Ecological Environmental Study Methodologies Useful for Public Health Projects. A Literature Review. Reviews of environmental contamination and toxicology. 2021;256:179-214;doi: 10.1007/398_2020_58.
2021 Osteresch R, Fach A, Frielitz FS, Meyer S, Schmucker J, R?hle S, Retzlaff T, Hadwiger M, H?rle T, Els?sser A, Katalinic A, Eitel I, Hambrecht R, Wienbergen H. Long-Term Effects of an Intensive Prevention Program After Acute Myocardial Infarction. Am J Cardiol. 2021;154:7-13;doi: 10.1016/j.amjcard.2021.05.034.
2021 Peters E, H?bner J, Katalinic A. [Stress, coping strategies and health-related quality of life during the corona pandemic in April 2020 in Germany]. Dtsch Med Wochenschr. 2021;146(2):e11-e20;doi: 10.1055/a-1275-3792.
2021 Pruessmann J, Pursche T, Hammersen F, Katalinic A, Fischer D, Waldmann A. Conditional Disease-Free and Overall Survival of 1,858 Young Women with Non-Metastatic Breast Cancer and with Participation in a Post-Therapeutic Rehab Programme according to Clinical Subtypes. Breast care (Basel, Switzerland). 2021;16(2):163-72;doi: 10.1159/000507315.
2021 Rudolph CES, Engholm G, Pritzkuleit R, Storm HH, Katalinic A. Survival of breast cancer patients in German-Danish border regions ? A registry-based cohort study. Cancer Epidemiol. 2021;74;doi: https://doi.org/10.1016/j.canep.2021.102001.
2021 Sacchetto L, Rosso S, Comber H, Bouchardy C, Broganelli P, Galceran J, Hackl M, Katalinic A, Louwman M, Robsahm TE, Tryggvadottir L, Tumino R, Van Eycken E, Walsh PM, Zadnik V, Zanetti R. Skin melanoma deaths within 1 or 3?years from diagnosis in Europe. Int J Cancer. 2021;148(12):2898-905;doi: 10.1002/ijc.33479.
2021 Struck JP, Schnoor M, Schulze A, Hupe MC, Ozimek T, Oppolzer IA, Schnabel MJ, Burger M, Darr C, Gruenwald V, Hadaschik B, Weinke M, Kuebler H, Klockenbusch JC, Grabbert MT, Gratzke C, Kramer MW, Katalinic A, Merseburger AS. Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals. World J Urol. 2021;40(2):409-18;doi: 10.1007/s00345-021-03868-2.
2021 Waldmann A, H?bner J, Katalinic A. Trends Over Time in Breast-Cancer-Specific Mortality in Germany. Dtsch ?rztebl Int. 2021;118(31-32):538-9;doi: 10.3238/arztebl.m2021.0182.
2021 Waldmann A, Pritzkuleit R, Labohm L, Katalinic A. Epidemiologie von Krebs im hohen Lebensalter. Forum. 2021;3:209-19;doi: https://doi.org/10.1007/s12312-021-00922-3.
2020 Arndt V, Holleczek B, Kaj?ter H, Luttmann S, Nennecke A, Zeissig SR, Kraywinkel K, Katalinic A. Data from Population-based Cancer Registration for Secondary Data Analysis: Methodological Challenges and Perspectives. Gesundheitswesen. 2020;82(S 01):62-71.
2020 Brunssen A, Jansen L, Eisemann N, Waldmann A, Weberpals J, Kraywinkel K, Eberle A, Holleczek B, Zeissig SR, Brenner H, Katalinic A. Long-term relative survival from melanoma in Germany 1997-2013. Melanoma Res. 2020;30(4):386-95.
2020 H?bner J, Katalinic A, Waldmann A, Kraywinkel K. Long-term Incidence and Mortality Trends for Breast Cancer in Germany. Geburtsh Frauenheilk. 2020;80(6):611-8.
2020 Hammersen F, Pursche T, Fischer D, Katalinic A, Waldmann A. Use of Complementary and Alternative Medicine among Young Patients with Breast Cancer. Breast Care. 2020;15(2):163-70.
2020 Jansen L, Holleczek B, Kraywinkel K, Weberpals J, Schr?der CC, Eberle A, Emrich K, Kaj?ter H, Katalinic A, Kieschke J, Nennecke A, Sirri E, Heil J, Schneeweiss A, Brenner H. Divergent Patterns and Trends in Breast Cancer Incidence, Mortality and Survival Among Older Women in Germany and the United States. Cancers (Basel). 2020;12(9).
2020 Minicozzi P, Vicentini M, Innos K, Castro C, Guevara M, Stracci F, Carmona-Garcia M, Rodriguez-Barranco M, Vanschoenbeek K, Rapiti E, Katalinic A, Marcos-Gragera R, Van Eycken L, Sanchez MJ, Bielska-Lasota M, Rossi PG, Sant M. Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study. Eur J Surg Oncol. 2020;46(6):1151-9.
2020 Sant M, Meneghini E, Bastos J, Rossi PG, Guevara M, Innos K, Katalinic A, Majuelo LG, Marcos-Gragera R, Molini? F, Rapiti E, Vizcaino A, Zadnik V, Minicozzi P. Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study. Breast Cancer Res Treat. 2020.
2020 Sirri E, Kieschke J, Vohmann C, Katalinic A, Nennecke A, Ressing M, Eberle A, Holleczek B, Jansen L, Brenner H. Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population-based study. Int J Cancer. 2020.
2019 Garbe C, Keim U, Eigentler TK, Amaral T, Katalinic A, Holleczek B, Martus P, Leiter U. Time trends in incidence and mortality of cutaneous melanoma in Germany. Journal of the European Academy of Dermatology and Venereology : JEADV. 2019;33(7):1272-80.
2019 H?bner J, H?bner F, Terheyden P, Katalinic A. [Turning point in skin cancer mortality : An analysis of the trend in Germany from 1998 to 2017]. Hautarzt. 2019;70(12):989-92.
2019 H?bner J, Lewin P, Pritzkuleit R, Eisemann N, Maier W, Katalinic A. Colorectal cancer screening by colonoscopy and trends in disease-specific mortality: a population-based ecological study of 358 German districts. Int J Colorectal Dis. 2019;34(4):599-605.
2019 Katalinic A, Eisemann N, Kraywinkel K, Noftz MR, H?bner J. Breast cancer incidence and mortality before and after implementation of the German mammography screening program. Int J Cancer. 2019.
2019 Rudolph C, Petersen GS, Pritzkuleit R, Storm H, Katalinic A. The acceptance and applicability of a patient-reported experience measurement tool in oncological care: a descriptive feasibility study in northern Germany. BMC Health Serv Res. 2019;19(1):786.
2019 Rudolph CES, Katalinic A. [Baseline Incidence of HPV-Associated Invasive and in Situ Cancers in Germany Prior to Potential Vaccination Effects]. Gesundheitswesen. 2019;81:993-1000.
2018 Eisemann N, Waldmann A, Holleczek B, Katalinic A. Observed and expected mortality in the German skin cancer screening pilot project SCREEN. J Med Screen. 2018;25(3):166-8.
2018 Jansen L, Buttmann-Schweiger N, Listl S, Ressing M, Holleczek B, Katalinic A, Luttmann S, Kraywinkel K, Brenner H, Workgroup GCS. Differences in incidence and survival of oral cavity and pharyngeal cancers between Germany and the United States depend on the HPV-association of the cancer site. Oral oncology. 2018;76:8-15.
2018 Pulte D, Weberpals J, Schroder CC, Emrich K, Holleczek B, Katalinic A, Luttmann S, Sirri E, Jansen L, Brenner H. Survival of patients with hepatobiliary tract and duodenal cancer sites in Germany and the United States in the early 21st century. Int J Cancer. 2018;143(2):324-32.
2017 Chen T, Brenner H, Fallah M, Jansen L, Castro FA, Geiss K, Holleczek B, Katalinic A, Luttmann S, Sundquist K, Ressing M, Xu L, Hemminki K. Risk of second primary cancers in women diagnosed with endometrial cancer in German and Swedish cancer registries. Int J Cancer. 2017;141(11):2270-80.
2017 H?bner J, Waldmann A, Geller AC, Weinstock MA, Eisemann N, Noftz M, Bertram S, Nolte S, Volkmer B, Greinert R, Breitbart E, Katalinic A. Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma. Br J Cancer. 2017;116(2):253-9.
2017 Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, Scheufele R, Wirth MP, Huber J. Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study. Prostate Cancer Prostatic Dis. 2017;20(1):61-6.
2017 Leiter U, Keim U, Eigentler T, Katalinic A, Holleczek B, Martus P, Garbe C. Incidence, Mortality and Trends of Non-Melanoma Skin Cancer in Germany. J Invest Dermatol. 2017;137(9):1860-7.
2017 Pritzkuleit R, Katalinic A, Gieseler F. Krebsregister und Gesundheitswesen. Anfragen bei Verdacht auf Krebsh?ufungen, Erwartungen und Bef?rchtungen. Onkologe. 2017;23(4).
2017 Pulte D, Weberpals J, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Brenner H. Survival for patients with rare haematologic malignancies: Changes in the early 21st century. Eur J Cancer. 2017;84:81-7.
2017 Weberpals J, Pulte D, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Merz M, Brenner H. Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States in the early 21st century. Haematologica. 2017;102(6):e229-e32.
2016 Brenner H, Castro FA, Eberle A, Emrich K, Holleczek B, Katalinic A, Jansen L, GEKID Cancer Survival Workgroup. Death certificate only proportions should be age adjusted in studies comparing cancer survival across populations and over time. Eur J Cancer. 2016;52:102-8.
2016 Brenner H, Schrotz-King P, Holleczek B, Katalinic A, Hoffmeister M. Declining Bowel Cancer Incidence and Mortality in Germany. Dtsch ?rztebl Int. 2016;113(7):101-6.
2016 Chen T, Fallah M, Brenner H, Jansen L, Mai EK, Castro FA, Katalinic A, Emrich K, Holleczek B, Geiss K, Eberle A, Sundquist K, Hemminki K, Gekid Cancer Survival Working Group. Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries. Sci Rep. 2016;6:22084.
2016 Eisemann N, Jansen L, Castro FA, Chen T, Eberle A, Nennecke A, Zeissig SR, Brenner H, Katalinic A, Group GCSW. Survival with nonmelanoma skin cancer in Germany. Br J Dermatol. 2016;174(4):778-85.
2016 Eisemann N, Schnoor M, Katalinic A. Prediction of chronic lymphocytic leukaemia incidence in Germany and of patients ineligible for standard chemotherapy. Hematol Oncol. 2016;34(2):93-101.
2016 Heywang-Kobrunner SH, Schreer I, Hacker A, Noftz MR, Katalinic A. Conclusions for mammography screening after 25-year follow-up of the Canadian National Breast Cancer Screening Study (CNBSS). Eur Radiol. 2016;26(2):342-50.
2016 Katalinic A. Improved prognosis for symptom-free older women with mammography-detected breast cancer? Strahlenther Onkol. 2016;192(2):130-2.
2016 Merz M, Jansen L, Castro FA, Hillengass J, Salwender H, Weisel K, Scheid C, Luttmann S, Emrich K, Holleczek B, Katalinic A, Nennecke A, Straka C, Langer C, Engelhardt M, Einsele H, Kr?ger N, Beelen D, Dreger P, Brenner H, Goldschmidt H, GEKID Cancer Survival Working Group and the DRST. Survival of elderly patients with multiple myeloma-Effect of upfront autologous stem cell transplantation. Eur J Cancer. 2016;62:1-8.
2016 Peller M, Katalinic A, Wollenberg B, Teudt IU, Meyer JE. Epidemiology of laryngeal carcinoma in Germany, 1998-2011. Eur Arch Otorhinolaryngol. 2016;273(6):1481-7.
2016 Pulte D, Castro FA, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Brenner H, GEKID Cancer Survival Working Group. Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century. J Hematol Oncol. 2016;9(1):28.
2016 Pulte D, Jansen L, Castro FA, Krilaviciute A, Katalinic A, Barnes B, Ressing M, Holleczek B, Luttmann S, Brenner H, GEKID Cancer Survival Working Group. Survival in patients with acute myeloblastic leukemia in Germany and the United States: Major differences in survival in young adults. Int J Cancer. 2016;139(6):1289-96.
2016 Sirri E, Castro FA, Kieschke J, Jansen L, Emrich K, Gondos A, Holleczek B, Katalinic A, Urbschat I, Vohmann C, Brenner H. Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States. Pancreas. 2016;45(6):908-14.
2015 Castro FA, Jansen L, Krilaviciute A, Katalinic A, Pulte D, Sirri E, Ressing M, Holleczek B, Luttmann S, Brenner H, GEKID Cancer Survival Working Group. Survival of patients with gastric lymphoma in Germany and in the United States. J Gastroenterol Hepatol. 2015;30(10):1485-91.
2015 Chen T, Fallah M, Jansen L, Castro FA, Krilavicuite A, Katalinic A, Eisemann N, Emrich K, Holleczek B, Geiss K, Eberle A, Sundquist J, Brenner H, Hemminki K, Group GCSW. Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries. Cancer letters. 2015;369(1):152-66.
2015 Eberle A, Jansen L, Castro F, Krilaviciute A, Luttmann S, Emrich K, Holleczek B, Nennecke A, Katalinic A, Brenner H, Group GSW. Lung cancer survival in Germany: A population-based analysis of 132,612 lung cancer patients. Lung cancer. 2015;90(3):528-33.
2015 Gebauer J, Fick EM, Waldmann A, Langer T, Kreitschmann-Andermahr I, Lehnert H, Katalinic A, Brabant G. Self-reported endocrine late effects in adults treated for brain tumours, Hodgkin and non-Hodgkin lymphoma - a registry based study in Northern Germany. Eur J Endocrinol. 2015;173(2):139-48.
2015 Jansen L, Castro FA, Gondos A, Krilaviciute A, Barnes B, Eberle A, Emrich K, Hentschel S, Holleczek B, Katalinic A, Brenner H, GEKID Cancer Survival Working Group. Recent cancer survival in Germany: an analysis of common and less common cancers. Int J Cancer. 2015;136(11):2649-58.
2015 Pulte D, Jansen L, Castro FA, Emrich K, Katalinic A, Holleczek B, Brenner H, GEKID Cancer Survival Working Group. Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century. Br J Haematol. 2015.
2015 Rudolph C, Schnoor M, Eisemann N, Katalinic A. Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010. J Dtsch Dermatol Ges. 2015;13(8):788-97.
2015 Sant M, Chirlaque Lopez MD, Agresti R, Sanchez Perez MJ, Holleczek B, Bielska-Lasota M, Dimitrova N, Innos K, Katalinic A, Langseth H, Larranaga N, Rossi S, Siesling S, Minicozzi P, Group E-W. Survival of women with cancers of breast and genital organs in Europe 1999-2007: results of the EUROCARE-5 study. Eur J Cancer. 2015.
2015 Storm HH, Engholm G, Pritzkuleit R, Kejs AM, Katalinic A, Dunst J, Hollander NH. Less pitfalls and variation in population based cancer survival comparisons within the European Union: Lessons from colorectal cancer patients in neighbouring regions in Denmark and Germany - The Fehmarn Belt project. Eur J Cancer. 2015;51(9):1188-98.
2014 Eisemann N, Waldmann A, Geller AC, Weinstock MA, Volkmer B, Greinert R, Breitbart EW, Katalinic A. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. J Invest Dermatol. 2014;134(1):8.
2014 Eisemann N, Waldmann A, Katalinic A. Inzidenz des malignen Melanoms und Ver?nderung der stadienspezifischen Inzidenz nach Einf?hrung eines Hautkrebsscreenings in Schleswig-Holstein. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014;57(1):7.
2014 Jansen L, Eberle A, Emrich K, Gondos A, Holleczek B, Kaj?ter H, Maier W, Nennecke A, Pritzkuleit R, Brenner H, GEKID Cancer Survival Working Group. Socioeconomic deprivation and cancer survival in Germany: an ecological analysis in 200 districts in Germany. Int J Cancer. 2014;134(12):2951-60.
2014 Pulte D, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Brenner H, GEKID Cancer Survival Working Group. Improved population level survival in younger Hodgkin lymphoma patients in Germany in the early 21st century. Br J Haematol. 2014;164(6):851-7.
2014 Pulte D, Jansen L, Gondos A, Katalinic A, Barnes B, Ressing M, Holleczek B, Eberle A, Brenner H, GEKID Cancer Survival Working Group. Survival of adults with acute lymphoblastic leukemia in Germany and the United States. PLoS One. 2014;9(1):e85554.
2014 Storm HH, Engholm G, Pritzkuleit R, Kejs AM, Katalinic A, Dunst J, Holl?nder NH. Less pitfalls and variation in population based cancer survival comparisons within the European Union: Lessons from colorectal cancer patients in neighbouring regions in Denmark and Germany - The Fehmarn Belt project. Eur J Cancer. 2014.
2013 Eisemann N, Waldmann A, Katalinic A. Epidemiology of Breast Cancer ? Current Figures and Trends. Geburtsh Frauenheilk. 2013;73(2):130?5.
2013 Katalinic A, Richter A, Babaev V, Pritzkuleit R. Krebsregistrierung im europ?ischen und nichteurop?ischen Ausland. Was k?nnen wir lernen? Onkologe. 2013;19:1025?36
2013 Listl S, Jansen L, Stenzinger A, Freier K, Emrich K, Holleczek B, Katalinic A, Gondos A, Brenner H, GEKID Cancer Survival Working Group. Survival of patients with oral cavity cancer in Germany. PLoS One. 2013;8(1):e53415.
2013 Liu H, Hemminki K, Sundquist J, Holleczek B, Katalinic A, Emrich K, Jansen L, Brenner H, GEKID Cancer Survival Working Group. A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects. Cancer Med. 2013;2(5):718-24.
2013 Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, Nennecke A, Eberle A, Brenner H, GEKID Cancer Survival Working Group. Sex differences in colorectal cancer survival: population-based analysis of 164,996 colorectal cancer patients in Germany. PLoS One. 2013;8(7):e68077.
2013 Rusner C, Trabert B, Katalinic A, Kieschke J, Emrich K, Stang A, Network of German Cancer Registries (GEKID). Incidence patterns and trends of malignant gonadal and extragonadal germ cell tumors in Germany, 1998-2008. Cancer Epidemiol. 2013;37(4):370-3.
2013 Stang A, Jansen L, Trabert B, Rusner C, Eberle A, Katalinic A, Emrich K, Holleczek B, Brenner H, GEKID Cancer Survival Working Group. Survival after a diagnosis of testicular germ cell cancers in Germany and the United States, 2002-2006: a high resolution study by histology and age. Cancer Epidemiol. 2013;37(4):492-7.
2013 Waldmann A, Eisemann N, Katalinic A. Epidemiology of Malignant Cervical, Corpus Uteri and Ovarian Tumours ? Current Data and Epidemiological Trends. Geburtsh Frauenheilk. 2013;73(2):123?9.
2012 Breitbart EW, Waldmann A, Nolte S, Capellaro M, Greinert R, Volkmer B, Katalinic A. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol. 2012;66(2):201-11.
2012 Chen T, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Meyer M, Brenner H. Survival of ovarian cancer patients in Germany in the early 21st century: a period analysis by age, histology, laterality, and stage. Eur J Cancer Prev. 2012;22(1):9.
2012 Chen T, Jansen L, Gondos A, Ressing M, Holleczek B, Katalinic A, Brenner H. Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage. BMC Cancer. 2012;12(1):128.
2012 Eisemann N, Jansen L, Holleczek B, Waldmann A, Luttmann S, Emrich K, Hauschild A, Brenner H, Katalinic A, GEKID Survival Working Group. Up-to-date results on survival of patients with melanoma in Germany. Br J Dermatol. 2012;167(3):7.
2012 Hertrampf K, Wiltfang J, Katalinic A, Timm O, Wenz HJ. Recent trends in incidence and mortality of oral and pharyngeal cancer in Schleswig-Holstein in Northern Germany. Community Dent Health. 2012;29(4):6.
2012 Hiripi E, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Nennecke A, Brenner H. Survival of stomach and esophagus cancer patients in Germany in the early 21st century. Acta Oncol. 2012;51:9.
2012 Jansen L, Gondos A, Eberle A, Emrich K, Holleczek B, Katalinic A, Brenner H. Cancer survival in Eastern and Western Germany after the fall of the iron curtain. Eur J Epidemiol. 2012;27(9):5.
2012 Katalinic A, Waldmann A, Weinstock MA, Geller AC, Eisemann N, Greinert R, Volkmer B, Breitbart E. Does Skin Cancer Screening Save Lives? - An Observational Study Comparing Trends in Melanoma Mortality in Regions With and Without Screening. Cancer. 2012;118(21):8.
2012 Liu H, Hemminki K, Sundquist J, Holleczek B, Katalinic A, Emrich K, Brenner H, Group GCSW. Second primary cancers after cancer of unknown primary in Sweden and Germany: efficacy of the modern work-up. Eur J Cancer Prev. 2012;22(3):5.
2012 Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, Nennecke A, Eberle A, Brenner H. Survival from colorectal cancer in Germany in the early 21st century. Br J Cancer. 2012;106:6.
2012 Pulte D, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Brenner H, the GCSWG. Survival of non-Hodgkin lymphoma patients in Germany in the early 21st century Leukemia & lymphoma. 2012;54(5):7.
2012 Rusner C, Bandemer-Greulich U, Engel J, Stegmaier C, Zawinell A, Holleczek B, Katalinic A, Kuss O, Schmidt-Pokrzywniak A, Schubert-Fritschle G, Tillack A, Stang A. Population-based hormone receptor-specific incidence trends of breast cancer in Germany. Maturitas. 2012;73(2):6.
2012 Schnoor M, Waldmann A, Eberle A, Holleczek B, Katalinic A. Colorectal cancer incidence in Germany: Stage-shift 6 years after implementation of a colonoscopy screening program. Cancer Epidemiol. 2012;36:4.
2012 Waldmann A, Nolte S, Weinstock MA, Breitbart EW, Eisemann N, Geller AC, Greinert R, Volkmer B, Katalinic A. Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening. Br J Cancer. 2012;106(5):5.
2011 Brenner H, Altenhofen L, Katalinic A, Lansdorp-Vogelaar I, Hoffmeister M. Sojourn Time of Preclinical Colorectal Cancer by Sex and Age: Estimates From the German National Screening Colonoscopy Database. Am J Epidemiol. 2011.
2011 Dittmer C, Katalinic A, Mundhenke C, Thill M, Fischer D. Epidemiology of vulvar and vaginal cancer in Germany. Arch Gynecol Obstet. 2011;284(1):169-74.
2011 Hakulinen T, Arbyn M, Brewster DH, Coebergh JW, Coleman MP, Crocetti E, Forman D, Gissler M, Katalinic A, Luostarinen T, Pukkala E, Rahu M, Storm H, Sund R, Tornberg S, Tryggvadottir L. Harmonization may be counterproductive--at least for parts of Europe where public health research operates effectively. Eur J Public Health. 2011;21(6):686-7.
2011 Hentschel S, Pritzkuleit R, Schmid-H?pfner S, Katalinic A. Epidemiologische Krebsregistrierung in Deutschland. Aufgaben und aktueller Status. Onkologe. 2011;17(2).
2011 Hertrampf K, Wiltfang J, Katalinic A, Timm O, Wenz HJ. Trends in incidence, tumour sites and tumour stages of oral and pharyngeal cancer in Northern Germany. J Cancer Res Clin Oncol. 2011.
2011 Hiripi E, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Sirri E, Brenner H. Survival from common and rare cancers in Germany in the early 21st century. Ann Oncol. 2011.
2010 Katalinic A, Emrich K, Luttmann S, Holleczek B, Stabenow R, Urbschat I, Meyer M. H?ufigkeiten, Trends und regionale Unterschiede von Krebserkrankungen in Deutschland. Pr?vention. 2010;33(4):99-102.
2010 Peters E, Pritzkuleit R, Beske F, Katalinic A. Demografischer Wandel und Krankheitsh?ufigkeiten. Eine Projektion bis 2050. Bundesgesundheitsbl. 2010;53(5):417-26.
2010 Pritzkuleit R, Beske F, Katalinic A. Demographischer Wandel und Krebserkrankungen in der Zukunft. Onkologie. 2010;33 (Suppl 7):19-24.
2010 Stang A, Katalinic A, Dieckmann KP, Pritzkuleit R, Stabenow R. A novel approach to estimate the German-wide incidence of testicular cancer. Cancer Epidemiol. 2010;34(1):13-9.
2009 Katalinic A, Lemmer A, Zawinell A, Rawal R, Waldmann A. Trends in hormone therapy and breast cancer incidence - Results from the German Network of Cancer Registries. Pathobiology. 2009;76(2):90-7.
2009 Katalinic A, Pritzkuleit R, Waldmann A. Recent Trends in Breast Cancer Incidence and Mortality in Germany. Breast Care. 2009;4:75-80.
2009 Pritzkuleit R, Katalinic A. R?umliche Karzinomanalyse: regionaler Vergleich der Inzidenz kolorektaler Karzinome in Bayern im Zeitraum 2006-2008. L?beck: Institut f?r Krebsepidemiologie; 2009.
2009 Waldmann A, Eberle A, Hentschel S, Holleczek B, Katalinic A. Bev?lkerungsbezogene Darmkrebsinzidenz im Zeitraum 2000 bis 2006 - Deuten sich erste Auswirkungen des Koloskopie-Screenings an? Eine gemeinsame Auswertung der Krebsregisterdaten aus Bremen, Hamburg, dem Saarland und Schleswig-Holstein
2009 Waldmann A, Rohde V, Bremner K, Krahn M, K?chler T, Katalinic A. Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reverence men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P). BMC Cancer. 2009;9.
2008 Katalinic A, Rawal R. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat. 2008;107(3):427-30.
2008 Pritzkuleit R, Waldmann A, Raspe H, Katalinic A. The population-based oncological health care study OVIS - Recruitment of the patients and analysis of the non-participants. BMC Cancer. 2008;8(1):311-23.
2007 Katalinic A, Rawal R. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat 2007.
2005 Lehnert M, Eberle A, Hentschel S, Katalinic A, Kieschke J, Schmidtmann I, Schubert-Fritschle G, Stegmaier C, Hense HW. [Malignant melanoma of the skin as evidenced by epidemiological cancer registries in Germany -- incidence, clinical parameters, variations in recording]. Gesundheitswesen 2005; 67(10):729-735.
2005 Stang A, Streller B, Katalinic A, Lehnert M, Eisinger B, Kaatsch P, Jockel KH. Incidence of Skin Lymphoma in Germany. Ann Epidemiol 2005.
2004 Gierspien K, Haartje U, Hentschel S, Katalinic A, Kieschke J. Tumorstadienverteilung in der Zielgruppe f?r das Mammographie-Screening. Deutsches ?rzteblatt 2004; 101(30):2117-2122.
2004 Katalinic A. Epidemiologische Krebsregistrierung in Deutschland - Bestandsaufnahme und Perspektiven. Bundesgesundheitsbl 2004; 47(5):422-428.
2003 Katalinic A, Holzmann M, Kunze U. Abh?ngigkeit der Tumorstadien von der Vollz?hligkeit der Registrierung bei Brustkrebs in einem bev?lkerungsbezogenen Krebsregister. Gesundheitswesen 2003; 65(8-9):509-515.
2003 Katalinic A, Kunze U, Sch?fer T. Epidemiology of cutaneous melanoma and non melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (Epidemiology of skin cancer). BJD 2003;(149):1200-1206.